These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells. Barbetti V, Gozzini A, Cheloni G, Marzi I, Fabiani E, Santini V, Dello Sbarba P, Rovida E. Epigenetics; 2013 Feb 12; 8(2):210-9. PubMed ID: 23321683 [Abstract] [Full Text] [Related]
9. Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons. Kumamaru E, Egashira Y, Takenaka R, Takamori S. Neurosci Lett; 2014 May 21; 569():142-7. PubMed ID: 24708928 [Abstract] [Full Text] [Related]
10. The activity of antiepileptic drugs as histone deacetylase inhibitors. Eyal S, Yagen B, Sobol E, Altschuler Y, Shmuel M, Bialer M. Epilepsia; 2004 Jul 21; 45(7):737-44. PubMed ID: 15230695 [Abstract] [Full Text] [Related]
11. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. Fortson WS, Kayarthodi S, Fujimura Y, Xu H, Matthews R, Grizzle WE, Rao VN, Bhat GK, Reddy ES. Int J Oncol; 2011 Jul 21; 39(1):111-9. PubMed ID: 21519790 [Abstract] [Full Text] [Related]
12. Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Balmer NV, Weng MK, Zimmer B, Ivanova VN, Chambers SM, Nikolaeva E, Jagtap S, Sachinidis A, Hescheler J, Waldmann T, Leist M. Hum Mol Genet; 2012 Sep 15; 21(18):4104-14. PubMed ID: 22723015 [Abstract] [Full Text] [Related]
13. Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition. Kidd SK, Schneider JS. Brain Res; 2010 Oct 01; 1354():172-8. PubMed ID: 20654591 [Abstract] [Full Text] [Related]
14. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells. Aztopal N, Erkisa M, Erturk E, Ulukaya E, Tokullugil AH, Ari F. Chem Biol Interact; 2018 Jan 25; 280():51-58. PubMed ID: 29225137 [Abstract] [Full Text] [Related]
15. Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2. Chandwani S, Keilani S, Ortiz-Virumbrales M, Morant A, Bezdecny S, Ehrlich ME. PLoS One; 2013 Jan 25; 8(10):e76842. PubMed ID: 24204683 [Abstract] [Full Text] [Related]
16. Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation. Marinova Z, Ren M, Wendland JR, Leng Y, Liang MH, Yasuda S, Leeds P, Chuang DM. J Neurochem; 2009 Nov 25; 111(4):976-87. PubMed ID: 19765194 [Abstract] [Full Text] [Related]
17. Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia. Singh V, Bhatia HS, Kumar A, de Oliveira AC, Fiebich BL. Neuroscience; 2014 Apr 18; 265():147-57. PubMed ID: 24480366 [Abstract] [Full Text] [Related]
18. Valproic acid induces apoptosis in differentiating hippocampal neurons by the release of tumor necrosis factor-α from activated astrocytes. Wang C, Luan Z, Yang Y, Wang Z, Cui Y, Gu G. Neurosci Lett; 2011 Jun 22; 497(2):122-7. PubMed ID: 21543053 [Abstract] [Full Text] [Related]
19. Inhibition of histone deacetylases class I improves adipogenic differentiation of human periodontal ligament cells. Serralta-Interian AA, Montero Del Toro J, Nic-Can GI, Rojas-Herrera R, Aguilar-Ayala FJ, Rodas-Junco BA. Cell Mol Biol (Noisy-le-grand); 2024 May 27; 70(5):40-47. PubMed ID: 38814236 [Abstract] [Full Text] [Related]
20. Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line. Balasubramanian D, Deng AX, Doudney K, Hampton MB, Kennedy MA. Neuropharmacology; 2015 Dec 27; 99():79-88. PubMed ID: 26151765 [Abstract] [Full Text] [Related] Page: [Next] [New Search]